Evidence map›Paper›PMID 32149006›Full record

ReviewKidney international supplements2020

Framework for establishing integrated kidney care programs in low- and middle-income countries.

Marcello Tonelli, Victoria Nkunu, Cherian Varghese, Ali K Abu-Alfa, Mona N Alrukhaimi, Louise Fox, John Gill, David C H Harris, Fan Fan Hou, Philip J O'Connell and 6 more

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in Kidney international supplements, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Global kidney health priorities-perspectives from the ISN-GKHA.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 14 institutions in 12 countries.

Marcello TonelliDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Victoria NkunuDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Cherian VargheseWorld Health Organization, Geneva, Switzerland.
Ali K Abu-AlfaDivision of Nephrology and Hypertension, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Mona N AlrukhaimiDepartment of Medicine, Dubai Medical College, Dubai, United Arab Emirates.
Louise FoxGreen Fox Consulting Ltd., Oxford, UK.
John GillDepartment of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
David C H HarrisCentre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Fan Fan HouState Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Philip J O'ConnellRenal Unit, University of Sydney at Westmead Hospital, Sydney, New South Wales, Australia.
Harun Ur RashidDepartment of Nephrology, Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh.
Abdou NiangDepartment of Nephrology, Dalal Jamm Hospital, Cheikh Anta Diop University Teaching Hospital, Dakar, Senegal.
Shahrzad OssarehDivision of Nephrology, Department of Medicine, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.
Vladimir TesarDepartment of Nephrology, General University Hospital, Charles University, Prague, Czech Republic.
Elena ZakharovaDepartment of Nephrology, Moscow City Hospital named after S.P. Botkin, Moscow, Russian Federation.
Chih-Wei YangKidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
The University of Sydney · AUUniversity of Calgary · CAAl Ain Hospital · AEAmerican University of Beirut · LBChang Gung University · TWCharles University · CZCheikh Anta Diop University · SNChild Health Research Foundation · BDDubai Medical College · AEIran University of Medical Sciences · IRMoscow State University of Medicine and Dentistry · RUNanfang Hospital · CNUniversity of British Columbia · CAWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

Secular increases in the burden of kidney failure is a major challenge for health systems worldwide, especially in low- and middle-income countries (LMICs) due to growing demand for expensive kidney replacement therapies. In LMICs with limited resources, the priority of providing kidney replacement therapies must be weighed against the prevention and treatment of chronic kidney disease, other kidney disorders such as acute kidney injury, and other noncommunicable diseases, as well as other urgent public health needs. Kidney failure is potentially preventable-not just through primary prevention of risk factors for kidney disease such as hypertension and diabetes, but also by timely management of established chronic kidney disease. Among people with established or incipient kidney failure, there are 3 key treatment strategies-conservative care, kidney transplantation, and dialysis-each of which has its own benefits. Joining up preventive care for people with or at risk for milder forms of chronic kidney disease with all 3 therapies for kidney failure (and developing synergistic links between the different treatment options) is termed "integrated kidney care" and has potential benefits for patients, families, and providers. In addition, because integrated kidney care implicitly considers resource use, it should facilitate a more sustainable approach to managing kidney failure than providing one or more of its components separately. There is currently no agreed framework that LMIC governments can use to establish and/or scale up programs to prevent and treat kidney failure or join up these programs to provide integrated kidney care. This review presents a suggested framework for establishing integrated kidney care programs, focusing on the anticipated needs of policy makers in LMICs.

Indexed as

chronicdialysiskidney-failurelow- and middle-income countrynoncommunicable diseasepalliationtransplantation

Identifiers

PMID32149006
PMCPMC7031683
OpenAlexW3007338165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.